Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas

@article{Apra2020FemaleGA,
  title={Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas},
  author={Caroline Apra and Paul Roblot and Abdu Alkhayri and Caroline Le Gu{\'e}rinel and Marc Polivka and Dorian Chauvet},
  journal={Journal of Neuro-Oncology},
  year={2020},
  volume={149},
  pages={101 - 95}
}
The great heterogeneity of meningiomas is challenging and we need to distinguish relevant subgroups. Spheno-orbital osteomeningiomas (SOOM) constitute a clinically specific entity, with slow-growing benign osteo-meningiomatous tumors, which recur after surgery in one fourth of cases. Neurosurgical daily practice, supported by the literature, shows that the vast majority of patients with SOOM are women, and we explored whether their epidemiological and hormonal profiles suggest a progesterone… 

Hormone therapies in meningioma-where are we?

Several clinical trials have recently been completed or are now underway using somatostatin analogs in combination with other therapies that appear promising, but a reevaluation of hormone-based monotherapy is warranted.

Have Progestin Related and Sporadic High Grade Meningiomas the Same Natural History?

Patients with Grade II progestin related meningiomas have less tumor recurrence after surgery than patients with sporadic high grade meningomas, especially after progest in withdrawal, according to a retrospective study.

Progestin-related WHO grade II meningiomas behavior—a single-institution comparative case series

WHO grade II progestin-related meningiomas have been reported in recent series but we found no previous study describing their long-term outcome. Our study aimed to evaluate patients operated on for

Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma

Patients with a history or current use of cyproterone acetate had significantly more meningiomas and were significantly younger at the onset, compared with the group without hormonal exposure.

Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study

A dose‐dependent association between the use of cyproterone acetate (CPA) and intracranial meningioma has been identified but data for other potent progestogens are scarce. The association was

Association of Hormonal Contraception with Meningioma Location in Indonesian Patients

A significant association between hormonal contraceptive use and meningioma location in the spheno-orbital region was found and resulted in the patients in the hormonal contraception group having more visual impairment.

References

SHOWING 1-10 OF 52 REFERENCES

Fertility treatment is associated with multiple meningiomas and younger age at diagnosis

Patients in this cohort with a history of fertility treatment were more likely to present at a younger age and have multiple and convexity/falx meningiomas, emphasizing the importance of taking estrogen/progesterone exposure history when evaluating patients withMeningioma.

Spheno-Orbital Meningiomas Surgery: Multicenter Management Study for Complex Extensive Tumors.

Internal and external spheno-orbital meningioma varieties: different outcomes and prognoses

The internal SOM variety exhibited a reduced total resection rate and a shorter progression-free survival (PFS) than the external variety, which could be replaced by prosthetic bone three-dimensional reconstruction.

Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression

Estrogen and androgen receptors may have more influence on the pathogenesis of meningiomas than earlier thought and can not be explained by differences of sex hormone receptor expression.

Spheno-orbital meningiomas: outcome after microsurgical treatment: a clinical review of 30 cases

Sufficient tumor control can be achieved with minimal morbidity and satisfying functional results in spheno-orbital meningiomas involving the sphenoid wing, orbit and important neurovascular structures.

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Data indicate that the presence of PRs, even in a small number of tumor cells, is a favorable prognostic factor for meningiomas, and that the absence of PR, high mitotic index, and higher tumor grade were significant factors for shorter disease-free intervals.

Sphenoorbital meningioma: a unique skull base tumor. Surgical technique and results.

Sphenoorbital meningioma is a unique skull base tumor that needs careful planning to optimize outcome, and proptosis and visual field defect other than a central scotoma can improve after surgery.

Surgical management of spheno-orbital meningiomas

It is felt that good tumor control of spheno-orbital meningiomas out morbidity is essential and that resection should be belimited up to the CS and SOF to achieve adequate tumor section with low morbidity.

Predictive factors for visual outcome after resection of spheno‐orbital meningiomas: a long‐term review

Initial proptosis and initial visual acuity were found to be negative predictive factors for final visual field defect and preoperative integrity of the optic canal and cavernous sinus, as observed radiologically, was a predictive factor for having no finalVisual field defect.
...